Literature DB >> 16166787

Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Michiko Miyamoto1, Takanobu Kato, Tomoko Date, Masashi Mizokami, Takaji Wakita.   

Abstract

Although replicon systems for hepatitis C virus (HCV) recently developed have enabled the replication of HCV in cultured cells, limited genotypes are available for them. We have isolated HCV cDNA of genotype 2a (JFH-1 strain) from serum of a patient with fulminant hepatitis. A subgenomic replicon of JFH-1 was constructed and compared with the HCV replicon of genotype 1b (Con1 NK5.1) which possessed adaptive mutations. Huh7 cells transfected with replicon RNAs that had been transcribed in vitro were cultured in the presence of neomycin sulfate (G418), and selected colonies were isolated and expanded. Then, growth rates and replication of HCV RNA were evaluated on isolated cells hosting replicons. Saturation densities were lower for cells propagating JFH-1 than Con1 NK5.1 or untransfected Huh7 cells, and the mean doubling time was longer for JFH-1 than for Huh7 cells. Levels of HCV RNA replication in isolated clones were similar between JFH-1 and Con1 NK5.1 cells. Replication of RNA decreased reciprocally with cell densities in both JFH-1 and Con1 NK5.1 cells. The replication of HCV RNA was more resistant to interferon-alpha in JFH-1 than in Con1 NK5.1 cells based on the comparison of an inhibitory concentration of 50%. In conclusion, we found differences between HCV replicon clones of genotypes 1b and 2a. However, these differences may result from strain-specific characteristics, such as the source of HCV, rather than characteristics of distinct genotypes. Therefore, further investigation may be needed on more HCV isolates of diverse genotypes. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16166787     DOI: 10.1159/000087261

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  20 in total

Review 1.  Mechanisms of HCV survival in the host.

Authors:  Ella H Sklan; Prista Charuworn; Philip S Pang; Jeffrey S Glenn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

2.  HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; Yasmine S el-Abd; Mahmoud M Bahgat; Hussein A Shoeb; Samar S Youssef; Noha G Bader el-Din; el-Rashdy M Redwan; Maha el-Demellawy; Moataza H Omran; Wael T el-Garf; Said A Goueli
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.

Authors:  Asako Murayama; Takanobu Kato; Daisuke Akazawa; Nao Sugiyama; Tomoko Date; Takahiro Masaki; Shingo Nakamoto; Yasuhito Tanaka; Masashi Mizokami; Osamu Yokosuka; Akio Nomoto; Takaji Wakita
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.

Authors:  Song Xu; Rongjuan Pei; Min Guo; Qingxia Han; Juan Lai; Yun Wang; Chunchen Wu; Yuan Zhou; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Production of infectious hepatitis C virus of various genotypes in cell cultures.

Authors:  Takanobu Kato; Takuya Matsumura; Theo Heller; Satoru Saito; Ronda K Sapp; Krishna Murthy; Takaji Wakita; T Jake Liang
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Diverse effects of cyclosporine on hepatitis C virus strain replication.

Authors:  Naoto Ishii; Koichi Watashi; Takayuki Hishiki; Kaku Goto; Daisuke Inoue; Makoto Hijikata; Takaji Wakita; Nobuyuki Kato; Kunitada Shimotohno
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

8.  Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.

Authors:  Sidhartha Hazari; Partha K Chandra; Bret Poat; Sibnarayan Datta; Robert F Garry; Timothy P Foster; Gus Kousoulas; Takaji Wakita; Srikanta Dash
Journal:  Virol J       Date:  2010-02-11       Impact factor: 4.099

9.  Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.

Authors:  Chaomin Sun; Cara T Pager; Guangxiang Luo; Peter Sarnow; Jamie H D Cate
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus.

Authors:  Brian Webster; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.